Experience of discordant βhCG results by different assays in the management of non-seminomatous germ cell tumours of the testis

Clinical Oncology

Volumn 11, Issue 6, 1999, Pages 388-392

  Summers, J ^a   Raggatt, P ^a   Pratt, J ^a   Williams, M V ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Assays; Discordance; Human chorionic gonadotropin (hCG); Non seminomatous germ cell tumours; Tumour markers

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; FLUOROIMMUNOASSAY; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; TESTIS TUMOR;

EID: 0033385594     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.1999.9089     Document Type: Article

References (17)

1. Kardana A, Elliott M M, Gawinowicz M -A. The heterogenicity of human chorionic gonadotrophin (hCG): 1. Characterisation of peptide heterogenicity in 13 individual preparations of hCG. Endocrinology. 129:1991;1541-1550.
2. Birken S, Gawinowicz M -A, Kardana A. The heterogenicity of human chorionic gonadotropin (hCG): 2. Characterisation and origins of nicks in hCG reference standards. Endocrinology. 129:1991;1551-1558.
3. Cole L A, Kardana A, Andrade-Gordon P. The heterogenicity of human chorionic gonadotropin (hCG): 3. The occurrence and biological and immunological activities of nicked hCG. Endocrinology. 129:1991;1559-1567.
4. Mead G M, Stenning S P, Parkinson M. The second Medical Research Council study of prognostic factors in non seminomatous germ cell tumours. J Clin Oncol. 10:1992;85-94.
5. Vaitukaitis J L, Braunstein G D, Ross G T. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of luteinising hormone. Am J Obstet Gynecol. 113:1972;751-758.
6. Cole L A, Kardana A. Discordant results in human chorionic gonadotropin assays. Clin Chem. 38:1992;263-270.
7. Germa J R, Angeles A, Roser C. False elevation of human chorionic gonadotropin associated with iatrogenic hypogonadism in gonadal germ cell tumours. Cancer. 60:1987;2489-2493.
8. Bulger K N, Hesketh P J, Babayan R K. Discordant human gonadotropin results giving rise to inapropriate therapy in a case of testicular cancer. J Urol. 142:1989;1574-1575.
9. Hussa R O, Rinke M L, Schweitzer P G. Discordant human chorionic gonadotropin results: causes and solutions. Obstet Gynecol. 65:1985;211-219.
10. Freedman L S, Parkinson M, Jones W G. Histopathology in the prediction of relapse of patients with Stage I testicular teratoma treated by orchidectomy alone. Lancet. ii:1987;294-298.
11. Mann K, Siddle K. Evidence for free bata subunit in socalled human chorionic gonadotropin positive seminoma. Cancer. 62:1988;2378-2382.
12. Horwich A, Peckham M J. Transient tumour marker elevation following chemotherapy for germ cell tumours of the testis. Cancer Treat Rep. 70:1986;1329-1331.
13. Le Blanc G A, Kantoff P W, NG S F. Hormonal perturbations in patients with testicular cancer treated with cisplatin. Cancer. 69:1992;2306-2310.
14. Stephanas A V, Samaan N A, Shultz P N. Endocrine studies in testicular tumour patients with and without gynecomastia. Cancer. 41:1978;369-376.
15. Cole L A, Seifer D B, Kardana A. Selecting human gonadotropin immunoassays: consideration of cross reacting molecules in first trimester pregnancy serum and urine. Am J Obstet Gynecol. 168:1992;1580-1586.
16. Madersbacher S, lieber R, Mann K. Free alpha subunit/free beta subunit of chorionic gonadotropin (hCG) and intact hCG in sera of healthy individuals and testicular cancer patients. Clin Chem. 38:1992;370-376.
17. Saller B, Clara R, Spottl G. Testicular cancer secretes intact chorionic gonadotropin (hCG) and its free beta subunit. Evidence that hCG (and hCG-β) assays are the most reliable in diagnosis and follow-up. Clin Chem. 36:1990;234-239.